Correlation Between Cytosorbents Crp and 908 Devices

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cytosorbents Crp and 908 Devices at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytosorbents Crp and 908 Devices into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cytosorbents Crp and 908 Devices, you can compare the effects of market volatilities on Cytosorbents Crp and 908 Devices and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytosorbents Crp with a short position of 908 Devices. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytosorbents Crp and 908 Devices.

Diversification Opportunities for Cytosorbents Crp and 908 Devices

0.41
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Cytosorbents and 908 is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Cytosorbents Crp and 908 Devices in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 908 Devices and Cytosorbents Crp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytosorbents Crp are associated (or correlated) with 908 Devices. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 908 Devices has no effect on the direction of Cytosorbents Crp i.e., Cytosorbents Crp and 908 Devices go up and down completely randomly.

Pair Corralation between Cytosorbents Crp and 908 Devices

Given the investment horizon of 90 days Cytosorbents Crp is expected to generate 1.04 times more return on investment than 908 Devices. However, Cytosorbents Crp is 1.04 times more volatile than 908 Devices. It trades about 0.02 of its potential returns per unit of risk. 908 Devices is currently generating about -0.04 per unit of risk. If you would invest  101.00  in Cytosorbents Crp on September 1, 2024 and sell it today you would lose (4.00) from holding Cytosorbents Crp or give up 3.96% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Cytosorbents Crp  vs.  908 Devices

 Performance 
       Timeline  
Cytosorbents Crp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cytosorbents Crp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Cytosorbents Crp may actually be approaching a critical reversion point that can send shares even higher in December 2024.
908 Devices 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 908 Devices has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Cytosorbents Crp and 908 Devices Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cytosorbents Crp and 908 Devices

The main advantage of trading using opposite Cytosorbents Crp and 908 Devices positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytosorbents Crp position performs unexpectedly, 908 Devices can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 908 Devices will offset losses from the drop in 908 Devices' long position.
The idea behind Cytosorbents Crp and 908 Devices pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Fundamental Analysis
View fundamental data based on most recent published financial statements